According to the ESC, what is the class recommendation for DCB in the treatment of ISR?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Practice for Clinical Training 1 (CT1) Day 4 Exam. Enhance your skills with a range of questions designed to test your clinical knowledge. Each question features detailed explanations to help you succeed.

Multiple Choice

According to the ESC, what is the class recommendation for DCB in the treatment of ISR?

Explanation:
In the context of the European Society of Cardiology (ESC) guidelines, a class recommendation of 1A indicates strong evidence and unanimous agreement on the efficacy and safety of drug-coated balloons (DCB) in the treatment of in-stent restenosis (ISR). This classification emphasizes that DCBs are considered not only effective but also the preferred treatment option for patients with ISR. The class 1 designation means there is substantial evidence from several high-quality studies supporting the use of DCB, showcasing better outcomes compared to other treatment methods in this specific clinical scenario. The addition of "A" further signifies that this recommendation is based on high-quality evidence, suggesting a high degree of confidence in the benefits of using DCBs, which can lead to improved patient outcomes such as reduced rates of restenosis and repeat procedures. In summary, the selection of D for the class recommendation reflects an understanding that DCB is a well-established and highly recommended intervention for ISR, with a robust evidence base backing its use.

In the context of the European Society of Cardiology (ESC) guidelines, a class recommendation of 1A indicates strong evidence and unanimous agreement on the efficacy and safety of drug-coated balloons (DCB) in the treatment of in-stent restenosis (ISR). This classification emphasizes that DCBs are considered not only effective but also the preferred treatment option for patients with ISR.

The class 1 designation means there is substantial evidence from several high-quality studies supporting the use of DCB, showcasing better outcomes compared to other treatment methods in this specific clinical scenario. The addition of "A" further signifies that this recommendation is based on high-quality evidence, suggesting a high degree of confidence in the benefits of using DCBs, which can lead to improved patient outcomes such as reduced rates of restenosis and repeat procedures.

In summary, the selection of D for the class recommendation reflects an understanding that DCB is a well-established and highly recommended intervention for ISR, with a robust evidence base backing its use.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy